Search Results - odf

Palivizumab Biosimilar C021P.05 Syd Labs

Palivizumab Biosimilar, Endotoxin 0.05 EU/mg | C021P.05

Palivizumab Biosimilar, Endotoxin 0.05 EU/mg. Palivizumab biosimilar CHO stable cell line is available for licensing to manufacture the palivizumab biosimilar protein. The research grade palivizumab biosimilar protein is for research use only (RUO). Recombinant human...

Panitumumab Biosimilar, N297A Mutant C012P.NA Syd Labs

Panitumumab Biosimilar, N297A Mutant | C012P.NA

Panitumumab Biosimilar, N297A Mutant. Panitumab biosimilar CHO stable cell line is available for licensing to manufacture the panitumumab biosimilar protein. The research grade panitumab biosimilar protein is for research use only (RUO). Recombinant human IgG2...

Eculizumab Biosimilar C022P.NA Syd Labs

Eculizumab Biosimilar, N297A Mutant | C022P.NA

Eculizumab Biosimilar, N297A Mutant. Eculizumab biosimilar CHO stable cell line is available for licensing to manufacture the eculizumab biosimilar protein. The research grade eculizumab biosimilar protein is for research use only (RUO). Recombinant human IgG4...

Infliximab Biosimilar C011P.NA Syd Labs

Infliximab Biosimilar, N297A Mutant | C011P.NA

Infliximab Biosimilar, N297A Mutant. Infliximab biosimilar CHO stable cell line is available for licensing to manufacture the Infliximab biosimilar protein. The research grade infliximab biosimilar protein is for research use only (RUO). Recombinant human IgG1...